Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) after Frontline Therapy with Hyper-CVAD Regimens.

被引：0
|
作者：
Thomas, Deborah A.
O'Brien, Susan [1 ]
Rytting, Michael
Faderl, Stefan
Cortes, Jorge
Wierda, William G.
Ravandi, Farhad [1 ]
Kantarjian, Hagop M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：674 / 674
页数：1
相关论文
共 50 条
  • [31] Hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia.
    Koller, CA
    Kantarjian, HM
    Thomas, D
    OBrien, S
    Rios, MB
    Kornblau, S
    Murphy, S
    Keating, M
    BLOOD, 1997, 90 (10) : 1482 - 1482
  • [32] Comparison of two induction regimens, high dose cytarabine/mitoxantrone vs hyper-CVAD, for adult acute lymphoblastic leukemia/lymphoma.
    Jeong, WD
    Liu, DL
    Katragadda, S
    Shi, QH
    Ahmed, T
    Seiter, K
    BLOOD, 2005, 106 (11) : 226B - 226B
  • [33] Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens
    Jain, Preetesh
    Kantarjian, Hagop
    Jain, Nitin
    Short, Nicholas J.
    Yin, Cameron C.
    Kanagal-Shamanna, Rashmi
    Khoury, Joseph
    Konopleva, Marina
    Sasaki, Koji
    Kadia, Tapan M.
    Garris, Rebecca
    Pierce, Sherry
    Estrov, Zeev
    Wierda, William
    Cortes, Jorge
    O'Brien, Susan
    Ravandi, Farhad
    Jabbour, Elias
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : E595 - E597
  • [34] High-dose cytarabine-mitoxantrone versus hyper-CVAD in adult acute lymphoblastic leukemia and Burkitt's lymphoma: A single center experience of two induction regimens.
    Lamba, Gurpreet Singh
    Pawar, Rahul
    Marballi, Abhishek
    Lee, Sang-Joon
    Liu, Delong
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Hyper-CVAD Plus Ofatumumab As Frontline Therapy in CD20+Acute Lymphoblastic Leukemia: Updated Results of a Phase II Trial
    Maiti, Abhishek
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Khouri, Maria
    Thomas, Deborah A.
    Garcia-Manero, Guillermo
    Garris, Rebecca
    Cortes, Jorge E.
    Short, Nicholas J.
    Jain, Nitin
    Bose, Prithviraj
    Verstovsek, Srdan
    Konopleva, Marina
    Sasaki, Koji
    Issa, Ghayas C.
    Ghosn, Marie
    Schroeder, Heather M.
    Kadia, Tapan
    Daver, Naval
    O'Brien, Susan M.
    Jabbour, Elias J.
    BLOOD, 2017, 130
  • [36] Outcome after Frontline Therapy with the Hyper-CVAD and Imatinib Mesylate Regimen for Adults with De Novo or Minimally Treated Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)
    Thomas, Deborah A.
    Kantarjian, Hagop M.
    Cortes, Jorge
    Ravandi, Farhad
    Faderl, Stefan
    Jones, Dan
    Letvak, Laurie A.
    Kebriaei, Partow
    Champlin, Richard E.
    O'Brien, Susan
    BLOOD, 2008, 112 (11) : 1008 - 1008
  • [37] Phase II Study of the Frontline Hyper-CVAD in Combination with Ponatinib for Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    Sasaki, Koji
    Jabbour, Elias J.
    Ravandi, Farhad
    Daver, Naval G.
    Pemmaraju, Naveen
    Thomas, Deborah A.
    Khouri, Rita B.
    Yilmaz, Musa
    Kadia, Tapan M.
    Short, Nicholas J.
    Garris, Rebecca
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Konopleva, Marina
    Estrov, Zeev
    Jain, Nitin
    Wierda, William G.
    Jeanis, Twilla Victoria
    Cortes, Jorge E.
    O'Brien, Susan M.
    Kantarjian, Hagop M.
    BLOOD, 2016, 128 (22)
  • [38] Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma
    Abaza, Yasmin
    Kantarjian, Hagop M.
    Faderl, Stefan
    Jabbour, Elias
    Jain, Nitin
    Thomas, Deborah
    Kadia, Tapan
    Borthakur, Gautam
    Khoury, Joseph D.
    Burger, Jan
    Wierda, William
    O'Brien, Susan
    Konopleva, Marina
    Ferrajoli, Alessandra
    Kebriaei, Partow
    Dabaja, Bouthaina
    Kornblau, Steven
    Alvarado, Yesid
    Daver, Naval
    Pemmaraju, Naveen
    Bose, Prithviraj
    Thompson, Philip
    Al Azzawi, Hind
    Kelly, Mary R. N.
    Garris, Rebecca
    Jain, Preetesh
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Ravandi, Farhad
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (01) : 91 - 99
  • [39] Hyper-CVAD-Based Regimens in Adult Patients With Acute Lymphoblastic Leukemia
    Jabbour, Elias J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (09) : 547 - 549
  • [40] The hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia (B-ALL).
    Thomas, D
    Kantarjian, H
    Cortes, J
    O'Brien, S
    Pierce, S
    Faderl, S
    Murphy, S
    Albitar, M
    Keating, MJ
    BLOOD, 1998, 92 (10) : 402A - 402A
12345